Description

The Human PD1 / PDL2 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between programmed cell death 1 ligand 2 and its receptor programmed cell death protein 1 in the presence of potential inhibitors within 4 hours. 4-8 week development phase.